Altered Arsenic Disposition in Experimental Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is represented by a spectrum of liver pathologies ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). Liver damage sustained in the progressive stages of NAFLD may alter the ability of the liver to properly metabolize and eliminate xenobioti...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Canet, Mark J., Hardwick, Rhiannon N., Lake, April D., Kopplin, Michael J., Scheffer, George L., Klimecki, Walter T., Gandolfi, A. Jay, Cherrington, Nathan J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The American Society for Pharmacology and Experimental Therapeutics 2012
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3422539/
https://ncbi.nlm.nih.gov/pubmed/22699396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.112.046177
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg